The effects of stressful stimuli and hypothalamic-pituitary-adrenal axis activation are reversed by the melanin-concentrating hormone 1 receptor antagonist SNAP 94847 in rodents

Behavioural Brain Research

Volumn 197, Issue 2, 2009, Pages 284-291

  Smith, Daniel G ^a   Hegde, Laxminarayan G ^a   Wolinsky, Toni D ^a   Miller, Silke ^a   Papp, Mariusz ^b   Ping, Xiaoli ^a   Edwards, Tanya ^a   Gerald, Christophe P ^a   Craig, Douglas A ^a  

^a LUNDBECK RESEARCH USA   (United States)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Behavior; Hypothalamic pituitary adrenal axis; Melanin concentrating hormone; Rodent; Stress

Indexed keywords

CHLORDIAZEPOXIDE; CITALOPRAM; CORTICOTROPIN; IMIPRAMINE; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; MELANIN CONCENTRATING HORMONE RECEPTOR 1 ANTAGONIST; N [3 [1 [4 (3,4 DIFLUOROPHENOXY)BENZYL]PIPERIDIN 4 YL] 4 METHYLPHENYL]ISOBUTYRAMIDE; SNAP 94847; SUCROSE; UNCLASSIFIED DRUG;

ACUTE STRESS DISORDER; ANHEDONIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL STRESS; CHRONIC STRESS; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASE; DOSE RESPONSE; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; FLUID INTAKE; FORCED SWIMMING TEST; HYPERTHERMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY; SINGLE DRUG DOSE; STIMULUS; SUGAR INTAKE;

ADMINISTRATION, ORAL; ADRENOCORTICOTROPIC HORMONE; ANALYSIS OF VARIANCE; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MOTOR ACTIVITY; PIPERIDINES; PITUITARY-ADRENAL SYSTEM; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PITUITARY HORMONE; STRESS, PHYSIOLOGICAL;

EID: 58149359221     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2008.08.026     Document Type: Article

References (57)

1. Gispen-de Wied C.C., and Jansen L.M. The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems. Curr Psychiatry Rep 4 (2002) 166-170
2. Rasmusson A.M., Lipschitz D.S., Wang S., Hu S., Vojvoda D., Bremner J.D., et al. Increased pituitary and adrenal reactivity in premenopausal women with posttraumatic stress disorder. Biol Psychiatry 50 (2001) 965-977
3. van Praag H.M. Can stress cause depression?. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 891-907
4. Gold P.W., Goodwin F.K., and Chrousos G.P. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1). N Engl J Med 319 (1988) 348-353
5. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry 7 (2002) 254-275
6. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci USA 97 (2000) 325-330
7. McEwen B.S. Mood disorders and allostatic load. Biol Psychiatry 54 (2003) 200-207
8. Pissios P., and Maratos-Flier E. Melanin-concentrating hormone: from fish skin to skinny mammals. Trends Endocrinol Metab 14 (2003) 243-248
9. Rivera G., Bocanegra-Garcia V., Galiano S., Cirauqui N., Ceras J., Perez S., et al. Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity. Curr Med Chem 15 (2008) 1025-1043
10. Tsigos C., and Chrousos G.P. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res 53 (2002) 865-871
11. Jezova D., Bartanusz V., Westergren I., Johansson B.B., Rivier J., Vale W., et al. Rat melanin-concentrating hormone stimulates adrenocorticotropin secretion: evidence for a site of action in brain regions protected by the blood-brain barrier. Endocrinology 130 (1992) 1024-1029
12. Kennedy A.R., Todd J.F., Dhillo W.S., Seal L.J., Ghatei M.A., O'Toole C.P., et al. Effect of direct injection of melanin-concentrating hormone into the paraventricular nucleus: further evidence for a stimulatory role in the adrenal axis via SLC-1. J Neuroendocrinol 15 (2003) 268-272
13. Smith D.G., Davis R.J., Rorick-Kehn L., Morin M., Witkin J.M., McKinzie D.L., et al. Melanin-concentrating hormone-1 receptor modulates neuroendocrine, behavioral, and corticolimbic neurochemical stress responses in mice. Neuropsychopharmacology 31 (2006) 1135-1145
14. Ludwig D.S., Mountjoy K.G., Tatro J.B., Gillette J.A., Frederich R.C., Flier J.S., et al. Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus. Am J Physiol 274 (1998) E627-E633
15. Georgescu D., Sears R.M., Hommel J.D., Barrot M., Bolanos C.A., Marsh D.J., et al. The hypothalamic neuropeptide melanin-concentrating hormone acts in the nucleus accumbens to modulate feeding behavior and forced-swim performance. J Neurosci 25 (2005) 2933-2940
16. Gonzalez M.I., Vaziri S., and Wilson C.A. Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides 17 (1996) 171-177
17. Kela J., Salmi P., Rimondini-Giorgini R., Heilig M., and Wahlestedt C. Behavioural analysis of melanin-concentrating hormone in rats: evidence for orexigenic and anxiolytic properties. Regul Pept 114 (2003) 109-114
18. Monzon M.E., Varas M.M., and de Barioglio S.R. Anxiogenesis induced by nitric oxide synthase inhibition and anxiolytic effect of melanin-concentrating hormone (MCH) in rat brain. Peptides 22 (2001) 1043-1047
19. Chambers J., Ames R.S., Bergsma D., Muir A., Fitzgerald L.R., Hervieu G., et al. Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1. Nature 400 (1999) 261-265
20. Saito Y., Nothacker H.P., Wang Z., Lin S.H., Leslie F., and Civelli O. Molecular characterization of the melanin-concentrating-hormone receptor. Nature 400 (1999) 265-269
21. An S., Cutler G., Zhao J.J., Huang S.G., Tian H., Li W., et al. Identification and characterization of a melanin-concentrating hormone receptor. Proc Natl Acad Sci USA 98 (2001) 7576-7581
22. Sailer A.W., Sano H., Zeng Z., McDonald T.P., Pan J., Pong S.S., et al. Identification and characterization of a second melanin-concentrating hormone receptor, MCH-2R. Proc Natl Acad Sci USA 98 (2001) 7564-7569
23. Tan C.P., Sano H., Iwaasa H., Pan J., Sailer A.W., Hreniuk D.L., et al. Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expression. Genomics 79 (2002) 785-792
24. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., et al. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat Med 8 (2002) 825-830
25. Chaki S., Funakoshi T., Hirota-Okuno S., Nishiguchi M., Shimazaki T., Iijima M., et al. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J Pharmacol Exp Ther 313 (2005) 831-839
26. David D.J., Klemenhagen K.C., Holick K.A., Saxe M.D., Mendez I., Santarelli L., et al. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J Pharmacol Exp Ther 321 (2007) 237-248
27. Basso A.M., Bratcher N.A., Gallagher K.B., Cowart M.D., Zhao C., Sun M., et al. Lack of efficacy of melanin-concentrating hormone-1 receptor antagonists in models of depression and anxiety. Eur J Pharmacol 540 (2006) 115-120
28. Willner P. Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berlin) 134 (1997) 319-329
29. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52 (2005) 90-110
30. Chen C.A., Jiang Y., Lu K., Daniewska I., Mazza C.G., Negron L., et al. Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists part 2: A hybrid strategy combining key fragments of HTS hits. J Med Chem 50 (2007) 3883-3890
31. Jiang Y., Chen C.A., Lu K., Daniewska I., De L.J., Kong R., et al. Synthesis and SAR investigations for novel melanin-concentrating hormone 1 receptor (MCH1) antagonists Part 1. The discovery of arylacetamides as viable replacements for the dihydropyrimidinone moiety of an HTS hit. J Med Chem 50 (2007) 3870-3882
32. Fitzsimons J.T., and Simons B.J. The effect on drinking in the rat of intravenous infusion of angiotensin, given alone or in combination with other stimuli of thirst. J Physiol 203 (1969) 45-57
33. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229 (1977) 327-336
34. Kerman I.A., Bernard R., Rosenthal D., Beals J., Akil H., and Watson S.J. Distinct populations of presympathetic-premotor neurons express orexin or melanin-concentrating hormone in the rat lateral hypothalamus. J Comp Neurol 505 (2007) 586-601
35. Clegg D.J., Air E.L., Benoit S.C., Sakai R.S., Seeley R.J., and Woods S.C. Intraventricular melanin-concentrating hormone stimulates water intake independent of food intake. Am J Physiol Regul Integr Comp Physiol 284 (2003) R494-R499
36. 1-receptor antagonist on (palatable) food and water intake. Brain Res 1062 (2005) 32-38
37. Hegde LG, Ping X, Zhang X, Gundlah C, Chien-An C, Shaposhnik Z, et al. Evidence for mechanism of action of melanin-concentrating hormone-1 receptor antagonists in rodent models of anxiety and depression. Program No. 356.16.2004 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience, 2004. online 2004, (Abstract).
38. Lemke M.R., Brecht H.M., Koester J., Kraus P.H., and Reichmann H. Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole. J Neuropsychiatry Clin Neurosci 17 (2005) 214-220
39. Leventhal A.M., and Rehm L.P. The empirical status of melancholia: implications for psychology. Clin Psychol Rev 25 (2005) 25-44
40. Nestler E.J., and Carlezon Jr. W.A. The mesolimbic dopamine reward circuit in depression. Biol Psychiatry (2006)
41. Winograd-Gurvich C., Fitzgerald P.B., Georgiou-Karistianis N., Bradshaw J.L., and White O.B. Negative symptoms: a review of schizophrenia, melancholic depression and Parkinson's disease. Brain Res Bull 70 (2006) 312-321
42. Papp M., Moryl E., and Willner P. Pharmacological validation of the chronic mild stress model of depression. Eur J Pharmacol 296 (1996) 129-136
43. Sanchez C., Gruca P., and Papp M. R-citalopram counteracts the antidepressant-like effect of escitalopram in a rat chronic mild stress model. Behav Pharmacol 14 (2003) 465-470
44. Jensen J.B., Jessop D.S., Harbuz M.S., Mork A., Sanchez C., and Mikkelsen J.D. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11 (1999) 465-471
45. Roy M., David N.K., Danao J.V., Baribault H., Tian H., and Giorgetti M. Genetic inactivation of melanin-concentrating hormone receptor subtype 1 (mchr1) in mice exerts anxiolytic-like behavioral effects. Neuropsychopharmacology 31 (2006) 112-120
46. Posener J.A., Wang L., Price J.L., Gado M.H., Province M.A., Miller M.I., et al. High-dimensional mapping of the hippocampus in depression. Am J Psychiatry 160 (2003) 83-89
47. Malberg J.E., Eisch A.J., Nestler E.J., and Duman R.S. Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20 (2000) 9104-9110
48. Anderson R.J., Freedland K.E., Clouse R.E., and Lustman P.J. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001) 1069-1078
49. Kyrou I., Chrousos G.P., and Tsigos C. Stress, visceral obesity, and metabolic complications. Ann NY Acad Sci 1083 (2006) 77-110
50. Shearman L.P., Camacho R.E., Sloan S.D., Zhou D., Bednarek M.A., Hreniuk D.L., et al. Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats. Eur J Pharmacol 475 (2003) 37-47
51. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. text revision, (2000), American Psychiatric Press, Inc., Washington, DC
52. Spooren W.P., Schoeffter P., Gasparini F., Kuhn R., and Gentsch C. Pharmacological and endocrinological characterization of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). Eur J Pharmacol 435 (2002) 161-170
53. Pissios P., Frank L., Kennedy A.R., Porter D.R., Marino F.E., Liu F.F., et al. Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice. Biol Psychiatry (2008)
54. Smith D.G., Tzavara E.T., Shaw J., Luecke S., Wade M., Davis R., et al. Mesolimbic dopamine super-sensitivity in melanin-concentrating hormone-1 receptor-deficient mice. J Neurosci 25 (2005) 914-922
55. Krishnan V., Han M.H., Graham D.L., Berton O., Renthal W., Russo S.J., et al. Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131 (2007) 391-404
56. Lalonde R., and Qian S. Exploratory activity, motor coordination, and spatial learning in MCHR1 knockout mice. Behav Brain Res (2007)
57. Roy M., David N., Cueva M., and Giorgetti M. A study of the involvement of melanin-concentrating hormone receptor 1 (MCHR1) in murine models of depression. Biol Psychiatry 61 (2007) 174-180